Company / Operating Income
PLUS THERAPEUTICS, INC. Operating Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$14.7M
FY2025
5-year range
-$20.7M / -$13.3M
FY2021-FY2025
Trend
-10.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$31M in FY2015 to -$13M in FY2024.
Based on SEC 10-K filings.
-$15M in FY2025.
Improved from -$21M to -$15M over the past 7 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 10.3% year-over-year.
- Peak operating income was recorded in FY2024.
- Lowest operating income in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$14.7M | -10.3% |
| FY2024 | -$13.3M | +35.6% |
| FY2018 | -$20.7M | -5.0% |
| FY2017 | -$19.7M | -28.9% |
| FY2016 | -$15.3M | +50.2% |
| FY2015 | -$30.7M | -8.0% |
| FY2014 | -$28.4M | +3.4% |
| FY2013 | -$29.4M | -16.1% |
| FY2012 | -$25.3M | -17.5% |
| FY2011 | -$21.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026